Lv21
160 积分 2024-12-12 加入
Clinical Pathology in Nonclinical Toxicity Studies
3小时前
已完结
Toxicologic Neuropathology of Novel Biotherapeutics
29天前
已完结
Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2020 and 2021
1个月前
已完结
Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2022 and 2023
1个月前
已完结
A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis
1个月前
已完结
Restoring IL-2 to its cancer immunotherapy glory
1个月前
已完结
Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab
1个月前
已完结
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
1个月前
已完结
First‐in‐Human Dose Selection for T‐Cell Engaging Bispecific Antibodies
1个月前
已完结
A Phase-Appropriate Risk Assessment Strategy in Support of the Safety of Peptide and Oligonucleotide-Related Impurities
1个月前
已完结
皖公网安备34019202002308
